Echocardiography in the Evaluation of Pulmonary Embolism.

Cardiol Rev

From the Cardiology Division, Department of Medicine, New York Medical College/Westchester Medical Center, Valhalla, NY.

Published: June 2018

Pulmonary embolism is a major cause of mortality. Acute pulmonary embolism also encompasses a wide clinical spectrum of severity, ranging from asymptomatic silent disease to hemodynamic instability and shock. Echocardiography is a useful modality to improve treatment strategies for pulmonary embolus. Echocardiography plays a role in risk stratification at the time of diagnosis. The evaluation of the right ventricle (RV) has evolved over time. RV variables evaluated by echocardiography include RV size, RV/left ventricular ratio, RV fractional area of change, tricuspid annular plane systolic excursion, RV systolic pressure, and RV Tei index. It has also been used in determining treatment strategies and following the success of treatment. Multiple echocardiographic criteria have been studied to improve risk stratification and outcomes from pulmonary embolism. Further studies are needed to assess the appropriate quantitative echocardiographic parameters.

Download full-text PDF

Source
http://dx.doi.org/10.1097/CRD.0000000000000158DOI Listing

Publication Analysis

Top Keywords

pulmonary embolism
16
treatment strategies
8
risk stratification
8
pulmonary
5
echocardiography
4
echocardiography evaluation
4
evaluation pulmonary
4
embolism
4
embolism pulmonary
4
embolism major
4

Similar Publications

Background: The number of patients with hip and femoral fractures is increasing and is expected to further increase in upcoming years due to the ageing population and the life expectancy of the general population. In this analysis, we aimed to systematically assess the post-operative complications associated with the pre-operative use of Aspirin in patients undergoing surgery for hip or femoral fracture.

Methods: Common online databases: Google Scholar, Web of Science, MEDLINE, Cochrane database, EMBASE ( www.

View Article and Find Full Text PDF

Background: Osimertinib is the standard first-line treatment for advanced epidermal growth factor receptor (EGFR)-mutated NSCLC. However, treatment resistance is inevitable and increased c-Met protein expression correlates with resistance. Telisotuzumab vedotin (Teliso-V) is an antibody-drug conjugate that targets c-Met protein overexpression.

View Article and Find Full Text PDF

Venous thromboembolism (VTE), consisting of both deep vein thrombosis (DVT) and pulmonary embolism (PE), is an extremely common condition both in the United States and worldwide. Not only is the diagnosis associated with significant morbidity and mortality for patients, but also it imposes a deleterious financial burden on the US healthcare system. Diagnosis may be challenging due to variability in clinical presentation and requires a sequential workup including assessment of clinical pretest probability for VTE, D-dimer testing, and imaging.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!